This inventor holds 1 USPTO granted patent. Top assignee: Bard Peripheral Vascular, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Michael Tristan - Innovator in Medical Technology
Introduction
Michael Tristan is a notable inventor based in Maricopa, AZ (US). He has made significant contributions to the field of medical technology, particularly in the treatment of post-thrombotic syndrome. His innovative approach has led to the development of a unique medical apparatus that addresses this condition effectively.
Latest Patents
Michael holds a patent for an "Apparatus and method for treatment of post thrombotic syndrome." This medical apparatus features a thrombectomy device that is housed within a sheath lumen. The device is designed to be movable between an initial extended position and a retracted position. It includes a first elongate cannula with a distal tip, a guidewire lumen, and a perforated region that is in fluid communication with the guidewire lumen. Additionally, it incorporates a second elongate cannula that is configured to rotate, along with a mechanical thrombectomy whisk. A third elongate cannula is also part of the apparatus, featuring an inflatable balloon and an expandable embolic filter.
Career Highlights
Michael Tristan is currently employed at Bard Peripheral Vascular, Inc., where he continues to innovate in the medical device sector. His work focuses on developing advanced solutions for vascular health, contributing to improved patient outcomes.
Collaborations
Throughout his career, Michael has collaborated with talented individuals such as Benjamin Erlick and Matthew Gerveler. These partnerships have fostered a creative environment that encourages the development of groundbreaking medical technologies.
Conclusion
Michael Tristan's contributions to medical technology, particularly through his patent for treating post-thrombotic syndrome, highlight his role as an innovator in the field. His work at Bard Peripheral Vascular, Inc. and collaborations with colleagues further emphasize his commitment to advancing healthcare solutions.
